Brian McDaniel

Aspire to Inspire

Over the past decade, various topics related to human embryonic stem cells (hESCs) have garnered media coverage across multiple platforms. From being recognized as the most innovative treatment option for curing specific illnesses to being protested by activist groups and other institutions, hESC research has gained considerable public interest. As business expert Jason Hope explains, with encouraging initial scientific findings, and eager researchers hoping to establish the legitimacy of hESC studies as a mainstream medical practice.


Also, many start-ups, biotechnology giants, and independent companies continue to forge ahead with hESC-related projects. As increasingly connected individuals, advanced technologies, and the marriage of medicine and technology continue to develop rapidly, Jason Hope expects hESC research to remain in the limelight. Over two decades ago, scientists were first able to extract embryonic stem cells from human embryos, effectively growing them in a laboratory environment. These embryonic stem cells allowed researchers to create new, healthy cells for research purposes. 

Jason Hope and Social Networking


Since then, stem cell technology has dramatically expanded, allowing scientists to develop effective treatment options for diseases such as Alzheimer’s and cancer. In recent years, doctors have used embryonic stem cells for research and have also begun testing treatments for various diseases in clinical trials. Jason Hope, who has dedicated much of his philanthropic efforts within the medical field through organizations like the SENS Foundation.


In addition to being an expert in improving overall human health, Jason Hope also understands the inherent mistrust that can be formed by the general public as soon as companies make grandiose claims about products they haven’t yet thoroughly tested. While the activist investor wants to see hESC research thrive, he also hopes to prevent the misuse of the information derived from these studies. He urges the creation of stringent protocols allowing only licensed researchers to conduct stem cell research. 


Currently, there are no standards regarding how stem cell research should proceed, but Hope still holds out hope that the industry will take steps toward developing its guidelines. By combining his knowledge of science and technology,  the philanthropist believes it would be ideal if stem cell research were regulated more strictly than it is today. Jason Hope´s goal is to facilitate a global dialogue between all stakeholders in this emerging healthcare sector, including government agencies, private firms, and individual researchers.